Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic
Top Cited Papers
- 1 June 2003
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 160 (6), 1125-1132
- https://doi.org/10.1176/appi.ajp.160.6.1125
Abstract
OBJECTIVE: The authors assessed the efficacy and safety of the first long-acting atypical antipsychotic (long-acting injectable risperidone) in patients with schizophrenia. METHOD: In a 12-week, mu...Keywords
This publication has 22 references indexed in Scilit:
- A Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of SchizophreniaAmerican Journal of Psychiatry, 2002
- A Comparison of Risperidone and Haloperidol for the Prevention of Relapse in Patients with SchizophreniaNew England Journal of Medicine, 2002
- Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?American Journal of Psychiatry, 2002
- Compliance in asthmaRespiratory Medicine, 1999
- Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective DisorderArchives of General Psychiatry, 1999
- Compliance With Medication Regimens for Mental and Physical DisordersPsychiatric Services, 1998
- Guidelines for depot antipsychotic treatment in schizophreniaEuropean Neuropsychopharmacology, 1998
- Complications at site of injection of depot neurolepticsBMJ, 1995
- The Bioavailability and Pharmacokinetics of Oral and Depot Intramuscular Haloperidol in Schizophrenic PatientsThe Journal of Clinical Pharmacology, 1987
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987